Targeted prostate cancer treatment cuts risk of side effects, study suggests
An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
""focal therapy delivers excellent long-term cancer control across a broad range of patients"."
— Prof Hashim Ahmed , Academic
""I have no long-term issues at all and it feels pretty unfair that this isn't offered to men across the whole country.""
— Rob Huxford , Other
""Our hope is that this evidence marks the point where every suitable man is routinely offered focal therapy as part of his treatment choices, regardless of where he lives.""
— Paul Sayer , Activist
""Our National Cancer Plan sets out our ambition to transform cancer care, and backing innovations like focal therapy is exactly how we are delivering on that promise.""
— Preet Kaur Gill , Politician
Key People
Founder of the charity Prost8 UK.
Health Innovation and Safety Minister.
Joint senior author and consultant urologist at Imperial College London.
A patient who had focal therapy for prostate cancer in 2020.
Locations
All Coverage
An NHS trial over 10 years followed nearly 3,500 men who received focal therapy, a less invasive treatment.
Similar Stories
Related coverage based on topic and tags
How a rapid new test is helping brain tumour patients
A rapid new test for brain tumours that the NHS has started using can slash the time it takes for an accurate diagnosis from up to eight weeks to two hours.
September 25, 2026 at 06:50 AMEndometriosis trial gives hope to millions of women in pain like me
A £2.3m study will look at whether a personalised pain management plan can improve the quality of life of women who have the debilitating condition.
September 30, 2026 at 05:21 AMFrom weeks to hours - the rapid new test transforming brain tumour diagnosis
The test means patients can start treatment sooner and are spared weeks of uncertainty.
September 24, 2026 at 11:44 PMAstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination Reuters
October 2, 2026 at 06:58 AMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMFree counselling for blood cancer patients
Linc offers sessions online or in-person at The Forum in Gloucester to patients at any stage in their diagnosis, as well as their loved ones.
September 24, 2026 at 04:03 PM